Clinical Trials Directory

Trials / Completed

CompletedNCT01554826

Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

A Double - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion)(0.25ml Formulation for Pediatric Use)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
810 (actual)
Sponsor
Hualan Biological Engineering, Inc. · Industry
Sex
All
Age
6 Months – 36 Months
Healthy volunteers
Accepted

Summary

The clinical trial was designed to evaluate the immunogenicity and safety against pediatric Inactivated influenza vaccine (Split Virion) (0.25ml formulation) of Hualan administered on infants age 6 months to 36 months.

Detailed description

The clinical trial was designed randomized and double-blind. Participants included up to 810 persons (540 persons in test group and 270 persons in control group). Healthy 6-36 months infants were selected, whose guardians were volunteers and had signed the informed consent. Subjects were selected according to the inclusion and exclusion criteria. Every subject accepted 30min's observation in the hospital after vaccination and received periodic follow-up till the fourth week after the boost vaccination. Blood of subjects was collected at the third week after the boost vaccination for the analysis of the immunogenicity. During the test, the adverse reactions and detailed information were reported to the SFDA under the status of blinding every month. Unblinding was conducted after the completion of the follow-up of subjects.

Conditions

Interventions

TypeNameDescription
BIOLOGICALInfluenza Split Vaccine0.25ml, two doses (540 subjects were randomly assigned to receive the first dose, among them, 515 subjects received a boost dose); two doses were assigned to be vaccinated 4 weeks apart
BIOLOGICALInactivated Influenza Vaccine0.25ml, two doses (270 subjects were randomly assigned to receive the first dose; among them, 263 subjects received a boost dose); two doses was administrated at 4 weeks apart

Timeline

Start date
2009-03-01
Primary completion
2009-05-01
Completion
2010-02-01
First posted
2012-03-15
Last updated
2012-09-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01554826. Inclusion in this directory is not an endorsement.